首页> 外国专利> COMPOSITION CONTAINING SILVER METAL NANOPARTICLES AND A HYALURONATE SALT AS INTERMEDIATE IN THE PREPARATION OF TOPICAL PHARMACEUTICAL FORMULATIONS

COMPOSITION CONTAINING SILVER METAL NANOPARTICLES AND A HYALURONATE SALT AS INTERMEDIATE IN THE PREPARATION OF TOPICAL PHARMACEUTICAL FORMULATIONS

机译:含银金属微粒和透明质酸盐的中间体,用于制备药物配方

摘要

A process for preparing a composition (A) is disclosed containing an aqueous dispersion of a pharmaceutically acceptable hyaluronic acid salt, having a weight average molecular weight ranging from 1,000,000 and 1,400,000 in an amount of from 0.4 to 2% by weight based on the total composition weight and metal silver particles, having an average size of from 4 to 10 nm in a concentration of from 0.004 to 0.02% comprising the following steps: a) Preparing an aqueous solution of said pharmaceutically acceptable hyaluronic acid salt having the above molecular weight with a concentration comprised in the aforementioned range, b) Adding an aqueous solution of a silver salt, to the aqueous solution and an alkaline metal hydroxide until reaching a pH ranging from 9.8 to 12.5, and an Ag ion concentration of from 0.004 to 0.02% c) Letting react the mixture of step b) at temperature ranging from 20 to 65°C d) Neutralizing the reacted mixture of step c) with an organic acid. This composition A) s used as intermediate for preparing pellets (B), wherein said metal silver nanoparticles are dispersed within said pharmaceutically acceptable hyaluronate salt or film (C) or gel (C) obtained by addition of a filming or gelling polymer to said composition (A) previously neutralized with an organic acid. Topical compositions are also disclosed containing: • The pellets (B) • The film (C) or the gel (C) in combination with suitable excipients and/or diluents, to be used in particular in the treatment of wound and lesions in particular of skin, and vaginal mucosa.
机译:公开了一种组合物(A)的制备方法,其包含药学上可接受的透明质酸盐的水分散体,所述透明质酸盐的重均分子量为1,000,000至1,400,000,基于总组合物的量为0.4至2重量%。重量和金属银颗粒,其平均尺寸为4至10 nm,浓度为0.004至0.02%,包括以下步骤:a)制备具有上述分子量的所述药学上可接受的透明质酸盐的水溶液,用浓度在上述范围内; b)向该水溶液和碱金属氢氧化物中加入银盐水溶液,直至达到9.8至12.5的pH范围,且银离子浓度为0.004至0.02%c)使步骤b)的混合物在20至65℃的温度下反应。d)用有机酸中和步骤c)的反应混合物。该组合物A)用作制备粒料(B)的中间体,其中所述金属银纳米颗粒分散在所述药学上可接受的透明质酸盐或膜(C)或通过向所述组合物中添加成膜或胶凝聚合物而获得的凝胶(C)内。 (A)事先用有机酸中和。还公开了局部用组合物,其包含:•颗粒(B)•膜(C)或凝胶(C)与合适的赋形剂和/或稀释剂的组合,特别用于治疗伤口和皮损,特别是皮肤和阴道粘膜。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号